Klingenstein Fields & Co. LP Has $33.17 Million Position in Colgate-Palmolive (NYSE:CL)

Klingenstein Fields & Co. LP cut its stake in Colgate-Palmolive (NYSE:CL) by 0.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 319,566 shares of the company’s stock after selling 1,216 shares during the quarter. Colgate-Palmolive makes up 1.3% of Klingenstein Fields & Co. LP’s portfolio, making the stock its 26th biggest holding. Klingenstein Fields & Co. LP’s holdings in Colgate-Palmolive were worth $33,174,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the company. E Fund Management Hong Kong Co. Ltd. bought a new stake in Colgate-Palmolive in the second quarter worth approximately $25,000. Continuum Advisory LLC increased its position in Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after buying an additional 125 shares during the last quarter. Reston Wealth Management LLC bought a new position in Colgate-Palmolive during the third quarter valued at about $42,000. Gradient Investments LLC lifted its position in shares of Colgate-Palmolive by 150.4% in the second quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after buying an additional 400 shares during the last quarter. Finally, Financial Connections Group Inc. bought a new stake in shares of Colgate-Palmolive during the 2nd quarter worth about $68,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Down 0.4 %

Shares of CL stock opened at $93.33 on Monday. Colgate-Palmolive has a one year low of $74.22 and a one year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.28. The stock has a fifty day moving average price of $102.26 and a 200 day moving average price of $98.35. The stock has a market cap of $76.25 billion, a P/E ratio of 26.74, a price-to-earnings-growth ratio of 3.35 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.14%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s payout ratio is 57.31%.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Barclays boosted their target price on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a report on Monday, July 29th. Evercore ISI boosted their price objective on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. Hsbc Global Res lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Tuesday, October 29th. Finally, UBS Group upped their price target on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $105.11.

Insider Activity

In related news, insider Sally Massey sold 15,850 shares of the stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the transaction, the insider now owns 13,942 shares of the company’s stock, valued at $1,439,929.76. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the sale, the insider now directly owns 13,942 shares in the company, valued at $1,439,929.76. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 43,490 shares of company stock worth $4,486,063. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.